Curex review
An oral line at $199 across forty-five states, with no injection offered at any price.
The verdict
Curex publishes $199 a month for oral semaglutide across 45 states, read August 2026. It sells no injection, which makes the figure hard to compare against an injectable price.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide · Tirzepatide
- Form
- Oral
- States
- 45
- From
- $199/mo
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
- Availability
- 45 states
Curex sells oral semaglutide. There is no injectable line. Coverage is recorded in forty-five states, which is wide for this category.
Who writes the prescription, and what do they see?
A prescription is issued before shipping, and the published material describes the product rather than the clinician. The intake is not documented. Nothing states what review happens before a repeat order goes out.
Remote, built around a single product rather than a menu. Committing to one format is itself a choice, and it is the clearest thing Curex publishes about how it works.
What happens when the dose goes up?
Oral dosing escalates on its own schedule, and Curex publishes nothing about what $199 covers as that happens. The gap is the same one most sellers leave, on a format where the rungs differ from the injectable ones.
What the price includes
$199 a month is $1,194 over six months at a steady dose. Setting that against an injectable figure compares two different products: the formats differ in what a milligram delivers, so the cheaper number is not automatically the cheaper treatment.
What it claims, and what it cites
Compounded rather than manufactured. A pharmacy prepares it and the FDA does not review it before dispensing. The oral route is not the one the approved weight-loss products use.
Where it holds up, and where it does not
- Strength: Coverage recorded across 45 states
- Strength: A single published figure, no tiers to decode
- Strength: No injection means no format upsell
- Limitation: Oral only — no injectable option
- Limitation: Not comparable against injection prices
- Limitation: Nothing published about dose behavior
- Limitation: Five states are not served
What the evidence says about this kind of treatment
The assessment above is about Curex. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- A buyer who has decided against injections and wants one published figure.
- Wrong for
- A buyer comparing against injectable prices, or one who may want to switch formats later.
How Curex compares
| Seller | Who it suits | Go |
|---|---|---|
| Coivas | Readers comparing headline figures who will ask about dose and coverage before ordering | See Coivas → |
| Bon Health | Readers who want tirzepatide without the usual premium and can pick a commitment length | See Bon Health → |
More GLP-1 telehealth sellers reviews: Fidelity Medical ClinicFORMFoundFridaysGalaGenesis Health
Sponsored alternative
Synergy Rx
A reader who wants the oral and injectable rates for both molecules stated up front rather than after an intake form.
Check Synergy Rx availability →Frequently asked
- Is $199 comparable to an injection price?
- Not directly. The formats deliver a milligram differently, so a lower or higher number across formats is not by itself the cheaper treatment.
- Does Curex sell an injection?
- No. Oral semaglutide is the only line published, read August 2026.
- How many states are covered?
- Forty-five are recorded. Five are not served.
- Is Curex legit?
- Curex is a GLP-1 telehealth sellers service. Its stated availability: 45 states. What our record does not establish: whether it bills insurance and how its intake works. Ask for those in writing before you pay.
- Is Curex expensive compared with other GLP-1 telehealth sellers?
- Curex publishes a starting figure of $199/mo. Across the 112 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $76 to $299 with a median of $179, which puts Curex above the median. The other 8 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.